FRAZZETTO, EVELISE
 Distribuzione geografica
Continente #
NA - Nord America 291
EU - Europa 138
AS - Asia 96
SA - Sud America 29
AF - Africa 28
Totale 582
Nazione #
US - Stati Uniti d'America 282
IT - Italia 70
SG - Singapore 63
BR - Brasile 29
IE - Irlanda 26
CI - Costa d'Avorio 24
CN - Cina 19
DE - Germania 8
NL - Olanda 8
BE - Belgio 7
MX - Messico 6
RU - Federazione Russa 6
GB - Regno Unito 5
VN - Vietnam 4
CA - Canada 3
FI - Finlandia 2
IN - India 2
NG - Nigeria 2
PT - Portogallo 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
PH - Filippine 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 582
Città #
Santa Clara 88
Singapore 52
Chandler 37
Chicago 37
Dublin 26
Abidjan 24
Catania 14
Boardman 13
Milan 9
Ashburn 7
Brussels 7
Civitanova Marche 7
Jacksonville 7
Andover 6
Cambridge 6
Gravina di Catania 6
Lawrence 6
Amsterdam 5
Ciudad Obregón 5
Bremen 4
Council Bluffs 4
Dong Ket 4
Nanjing 4
Florence 3
Hefei 3
Los Angeles 3
Padova 3
Seattle 3
Toronto 3
Abuja 2
Brooklyn 2
Dakar 2
Des Moines 2
Jiaxing 2
Lisbon 2
Milazzo 2
New York 2
Palermo 2
Rotterdam 2
Aachen 1
Aci Catena 1
Alfenas 1
Amman 1
Barra do Garças 1
Batalha 1
Bauru 1
Belém 1
Biguaçu 1
Bishkek 1
Campos dos Goytacazes 1
Canicattini Bagni 1
Chopinzinho 1
Colombo 1
Contagem 1
Den Haag 1
Enna 1
Feltham 1
Goiânia 1
Grand Rapids 1
Hebei 1
Helsinki 1
Hortolândia 1
Itabira 1
Jacareí 1
Jaguariaíva 1
Joinville 1
Kilis 1
Kochi 1
Kunming 1
Kuçovë 1
Lappeenranta 1
Las Vegas 1
Lentini 1
London 1
Manchester 1
Manila 1
Mascalucia 1
Mays Landing 1
Mexico City 1
Moscow 1
Nanchang 1
Naples 1
New Delhi 1
Norwalk 1
Novy Urengoy 1
Palmital 1
Patos de Minas 1
Ponte Nova 1
Porto Alegre 1
Pozzo Di Gotto 1
Prague 1
Redmond 1
Reggio Emilia 1
Rio de Janeiro 1
Saint Petersburg 1
Senhor do Bonfim 1
Shanghai 1
Shenyang 1
Sorocaba 1
Southport 1
Totale 477
Nome #
Evaluation of health status in patients with hepatitis c treated with and without interferon 80
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 74
Rare benign tumors of the liver: still rare? 69
Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users 65
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 48
Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments 46
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 42
REAL-WORLD DATA ON LONG TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID FOR PRIMARY BILIARY CHOLANGITIS: FIRST RELEASE FROM THE ITALIAN RECAPITULATE STUDY 38
Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study 31
Development and validation of a score predicting response to obeticholic acid in primary biliary cholangitis: the OCA response score (ORS) 30
Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS) 25
PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS) 25
Direct oral anticoagulant treatment of deep vein thrombosis reduces IL‑6 expression in peripheral mono‑nuclear blood cells 24
Real-world data on the treatment of primary biliary cholangitis with obeticholic acid in Italy: the CLEO-AIGO OCA cohort 22
Totale 619
Categoria #
all - tutte 2.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/202132 1 0 1 1 8 0 6 0 4 4 2 5
2021/202241 3 7 0 0 7 0 7 2 5 0 0 10
2022/2023103 6 4 6 12 9 12 1 21 24 2 4 2
2023/202487 4 12 4 1 6 21 7 14 0 0 9 9
2024/2025307 0 59 15 14 68 54 5 8 20 39 24 1
Totale 619